Study of a major intermediate in the oxidative folding of leech carboxypeptidase inhibitor: Contribution of the fourth disulfide bond

被引:15
作者
Arolas, JL
Popowicz, GM
Bronsoms, S
Aviles, FX [1 ]
Huber, R
Holak, TA
Ventura, S
机构
[1] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain
[3] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
关键词
carboxypeptidase inhibitor; oxidative folding; folding intermediates; crystal structures; protein stability;
D O I
10.1016/j.jmb.2005.07.065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oxidative folding pathway of leech carboxypeptidase inhibitor (LCI; four disulfide bonds) proceeds through the formation of two major intermediates (III-A and III-B) that contain three native disulfide bonds and act as strong kinetic traps in the folding process. The III-B intermediate lacks the Cys19-Cys43 disulfide bond that links the beta-sheet core with the alpha-helix in wild-type LCI. Here, an analog of this intermediate was constructed by replacing Cys19 and Cys43 with alanine residues. Its oxidative folding follows a rapid sequential flow through one, two, and three disulfide species to reach the native form; the low accumulation of two disulfide intermediates and three disulfide (scrambled) isomers accounts for a highly efficient reaction. The three-dimensional structure of this analog, alone and in complex with carboxypeptidase A (CPA), was determined by X-ray crystallography at 2.2 angstrom resolution. Its overall structure is very similar to that of wild-type LCI, although the residues in the region adjacent to the mutation sites show an increased flexibility; which is strongly reduced upon binding to CPA. The structure of the complex also demonstrates that the analog and the wild-type LCI bind to the enzyme in the same manner, as expected by their inhibitory capabilities, which were similar for all enzymes tested. Equilibrium unfolding experiments showed that this mutant is destabilized by similar to 1.5 kcal mol(-1)(40%) relative to the wild-type protein. Together, the data indicate that the fourth disulfide bond provides LCI with both high stability and structural specificity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:961 / 975
页数:15
相关论文
共 52 条
[31]   T7 vectors with a modified T7lac promoter for expression of proteins in Escherichia coli [J].
Peranen, J ;
Rikkonen, M ;
Hyvonen, M ;
Kaariainen, L .
ANALYTICAL BIOCHEMISTRY, 1996, 236 (02) :371-373
[32]   Human procarboxypeptidase B:: Three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI) [J].
Pereira, PJB ;
Segura-Martín, S ;
Oliva, B ;
Ferrer-Orta, C ;
Avilés, FX ;
Coll, M ;
Gomis-Rüth, FX ;
Vendrell, J .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 321 (03) :537-547
[33]   A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis -: Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization [J].
Reverter, D ;
Vendrell, J ;
Canals, F ;
Horstmann, J ;
Avilés, FX ;
Fritz, H ;
Sommerhoff, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32927-32933
[34]   Overexpression of human procarboxypeptidase A2 in Pichia pastoris and detailed characterization of its activation pathway [J].
Reverter, D ;
Ventura, S ;
Villegas, V ;
Vendrell, J ;
Avilés, FX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3535-3541
[35]   Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2 [J].
Reverter D. ;
Fernández-Catalán C. ;
Baumgartner R. ;
Pfänder R. ;
Huber R. ;
Bode W. ;
Vendrell J. ;
Holak T.A. ;
Avilés F.X. .
Nature Structural Biology, 2000, 7 (4) :322-328
[36]   Major kinetic traps for the oxidative folding of leech carboxypeptidase inhibitor [J].
Salamanca, S ;
Li, L ;
Vendrell, J ;
Aviles, FX ;
Chang, JY .
BIOCHEMISTRY, 2003, 42 (22) :6754-6761
[37]   The unfolding pathway of leech carboxypeptidase inhibitor [J].
Salamanca, S ;
Villegas, V ;
Vendrell, J ;
Li, L ;
Aviles, FX ;
Chang, JY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17538-17543
[38]   Bovine pancreatic ribonuclease A: Oxidative and conformational folding studies [J].
Scheraga, HA ;
Wedemeyer, WJ ;
Welker, E .
RIBONUCLEASES, PT A, 2001, 341 :189-221
[39]   NMR structural analysis of an analog of an intermediate formed in the rate-determining step of one pathway in the oxidative folding of bovine pancreatic ribonuclease A: Automated analysis of H-1, C-13, and N-15 resonance assignments for wild-type and [C65S, C72S] mutant forms [J].
Shimotakahara, S ;
Rios, CB ;
Laity, JH ;
Zimmerman, DE ;
Scheraga, HA ;
Montelione, GT .
BIOCHEMISTRY, 1997, 36 (23) :6915-6929
[40]  
Silveira A, 2000, THROMB HAEMOSTASIS, V84, P364